Stock listing
gettex:B8S MiniMed Group, Inc. Aktie
German listing (gettex) of MiniMed Group, Inc. · home listing NASDAQ:MMED
Follow MiniMed Group, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MMED
$16.01 USD -0.98 (-5.8%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MMED
- Day range
- $15.92 – $16.79 USDNov 20, 2026
- Volume
- 4.57M sharesNov 20, 2026
- Market cap
- $4.50B USDAt the close on Nov 20, 2026 · price × 281.3M shares outstanding
- Traded on an average day
- $155.0M USDMedian day 4.70M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MMED · Home | $16.01 USD | -0.98 (-5.8%) | 4,573,375 | $16.08 | $16.79 | $15.92 | $16.99 | Close on Nov 20, 2026 |
| NASDAQ:MMEDV | $17.70 USD | 0.00 (0.0%) | 226,896 | $17.70 | $17.70 | $17.70 | $17.70 | Close on Oct 28, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MMED · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $16.01 | -0.98 | -5.8% | $16.08 | $16.79 | $15.92 | 4,573,375 | |
| $16.99 | -0.79 | -4.4% | $17.71 | $18.24 | $16.97 | 4,702,278 | |
| $17.78 | -0.87 | -4.7% | $18.59 | $18.60 | $17.74 | 4,988,035 | |
| $18.65 | +0.66 | +3.7% | $18.83 | $19.11 | $18.46 | 10,535,077 | |
| $17.99 | +0.115 | +0.6% | $17.88 | $18.15 | $17.65 | 5,337,774 | |
| $17.88 | -0.375 | -2.1% | $18.23 | $18.30 | $17.62 | 3,271,468 | |
| $18.25 | +0.89 | +5.1% | $17.46 | $18.66 | $17.25 | 5,553,688 | |
| $17.36 | -0.52 | -2.9% | $17.53 | $17.71 | $17.25 | 4,453,314 | |
| $17.88 | +1.17 | +7.0% | $16.98 | $17.89 | $16.78 | 6,135,751 | |
| $16.71 | -1.445 | -8.0% | $18.25 | $18.25 | $16.66 | 7,294,494 | |
| $18.16 | -1.135 | -5.9% | $19.63 | $19.63 | $17.75 | 9,559,628 | |
| $19.29 | +0.44 | +2.3% | $19.33 | $19.93 | $19.27 | 11,782,688 | |
| $18.85 | -0.05 | -0.3% | $18.77 | $19.05 | $18.51 | 5,713,732 | |
| $18.90 | +0.62 | +3.4% | $18.38 | $19.03 | $18.20 | 6,751,873 | |
| $18.28 | -0.97 | -5.0% | $19.48 | $19.48 | $18.04 | 8,133,981 | |
| $19.25 | +0.04 | +0.2% | $19.01 | $19.54 | $19.01 | 7,328,348 | |
| $19.21 | +0.28 | +1.5% | $18.87 | $19.32 | $18.60 | 10,305,080 | |
| $18.93 | +0.27 | +1.4% | $18.66 | $18.99 | $18.22 | 8,000,800 | |
| $18.66 | +0.32 | +1.7% | $18.29 | $18.69 | $18.07 | 5,287,805 | |
| $18.34 | +0.05 | +0.3% | $18.47 | $18.47 | $17.94 | 4,801,600 | |
| $18.29 | +0.49 | +2.8% | $17.69 | $18.35 | $17.56 | 9,782,000 | |
| $17.80 | +0.31 | +1.8% | $17.31 | $18.11 | $17.29 | 10,345,100 | |
| $17.49 | -0.30 | -1.7% | $18.10 | $18.13 | $17.36 | 10,860,700 | |
| $17.79 | +0.30 | +1.7% | $17.52 | $18.11 | $17.24 | 17,460,000 | |
| $17.49 | -0.51 | -2.8% | $17.70 | $18.00 | $17.38 | 21,451,400 | |
| $18.00 | +1.19 | +7.1% | $16.65 | $18.08 | $16.60 | 27,731,700 | |
| $16.81 | -1.59 | -8.6% | $18.17 | $18.40 | $16.56 | 67,620,800 | |
| $18.40 | -0.40 | -2.1% | $19.14 | $19.35 | $18.37 | 33,606,900 | |
| $18.80 | -0.91 | -4.6% | $18.87 | $19.49 | $18.46 | 38,550,600 | |
| $19.71 | -0.09 | -0.5% | $19.79 | $20.15 | $19.47 | 18,395,900 | |
| $19.80 | +0.69 | +3.6% | $19.08 | $19.83 | $18.94 | 23,336,100 | |
| $19.11 | -0.53 | -2.7% | $19.57 | $19.64 | $19.03 | 9,619,300 | |
| $19.64 | -0.52 | -2.6% | $19.79 | $20.00 | $19.40 | 15,506,300 | |
| $20.16 | +0.46 | +2.3% | $19.69 | $20.17 | $19.03 | 15,347,600 | |
| $19.70 | +0.10 | +0.5% | $19.53 | $19.98 | $19.29 | 4,695,100 | |
| $19.60 | +0.13 | +0.7% | $19.51 | $19.64 | $19.25 | 3,933,100 | |
| $19.47 | -0.57 | -2.8% | $20.07 | $20.12 | $19.44 | 4,024,500 | |
| $20.04 | -0.45 | -2.2% | $20.31 | $20.37 | $19.73 | 3,344,600 | |
| $20.49 | +0.51 | +2.6% | $19.97 | $20.51 | $19.80 | 3,729,700 | |
| $19.98 | -0.46 | -2.3% | $20.75 | $20.75 | $19.71 | 2,554,400 | |
| $20.44 | -0.10 | -0.5% | $20.69 | $21.03 | $20.29 | 3,413,500 | |
| $20.54 | -0.66 | -3.1% | $21.17 | $21.26 | $20.37 | 2,845,300 | |
| $21.20 | +0.08 | +0.4% | $21.68 | $21.69 | $20.99 | 2,803,900 | |
| $21.12 | -0.67 | -3.1% | $22.14 | $22.30 | $21.09 | 2,331,700 | |
| $21.79 | -0.24 | -1.1% | $22.10 | $22.17 | $21.74 | 2,881,500 | |
| $22.03 | -0.37 | -1.7% | $22.57 | $22.68 | $21.74 | 2,730,500 | |
| $22.40 | +0.39 | +1.8% | $22.14 | $23.36 | $22.09 | 4,068,100 | |
| $22.01 | +0.04 | +0.2% | $22.52 | $22.52 | $21.70 | 2,127,100 | |
| $21.97 | -0.53 | -2.4% | $21.50 | $22.73 | $21.27 | 4,386,500 | |
| $22.50 | +0.06 | +0.3% | $23.03 | $23.74 | $22.28 | 1,423,600 | |
| $22.44 | -0.32 | -1.4% | $22.54 | $23.17 | $22.10 | 1,651,100 | |
| $22.76 | -0.56 | -2.4% | $23.22 | $23.31 | $22.51 | 1,587,700 | |
| $23.32 | +0.03 | +0.1% | $23.16 | $23.44 | $22.74 | 1,052,100 | |
| $23.29 | -0.55 | -2.3% | $23.84 | $23.90 | $23.17 | 1,719,300 | |
| $23.84 | +0.08 | +0.3% | $23.88 | $24.16 | $23.19 | 4,268,100 | |
| $23.76 | +1.34 | +6.0% | $22.78 | $24.43 | $22.62 | 4,491,600 | |
| $22.42 | +2.16 | +10.7% | $20.40 | $22.74 | $19.65 | 6,075,200 | |
| $20.26 | +0.16 | +0.8% | $19.97 | $20.37 | $19.72 | 2,482,100 | |
| $20.10 | +0.59 | +3.0% | $19.77 | $20.25 | $19.60 | 1,329,300 | |
| $19.51 | +0.02 | +0.1% | $19.69 | $19.84 | $19.11 | 1,306,400 | |
| $19.49 | +0.57 | +3.0% | $18.86 | $19.56 | $18.85 | 1,244,600 | |
| $18.92 | -1.02 | -5.1% | $19.95 | $19.95 | $18.85 | 1,102,410 | |
| $19.94 | -0.51 | -2.5% | $20.45 | $20.68 | $19.63 | 910,671 | |
| $20.45 | +0.27 | +1.3% | $20.34 | $20.74 | $19.86 | 1,119,100 | |
| $20.18 | -0.04 | -0.2% | $20.07 | $20.84 | $19.79 | 1,424,500 |
- Ticker
- gettex:B8S
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
MiniMed Launches MiniMed Flex™, its Smallest and Most Discrete Insulin Pump, in Europe
Latest earnings call · Sep 1, 2026
MiniMed Group (NASDAQ:MMED) Q1 2027 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 42 slides
Latest news
MiniMed Launches MiniMed Flex™, its Smallest and Most Discrete Insulin Pump, in Europe
Nov 17, 2026
Closed $17.78 (-4.7%) on Nov 17, 2026
FDA Clears MiniMed Fit™ -- World's First and Only Tubeless Insulin Pump with Up to Seven-Day Wear and Zero Interruptions
Nov 16, 2026
Closed $18.65 (+3.7%) on Nov 16, 2026
MiniMed to Participate in Upcoming Investor Conferences
Nov 5, 2026
Closed $18.16 (-5.9%) on Nov 5, 2026
MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results
Nov 4, 2026
Closed $18.16 (-5.9%) on Nov 5, 2026
MiniMed Appoints Dr. David Segal as Chief Medical Officer
Nov 3, 2026
Closed $18.85 (-0.3%) on Nov 3, 2026
MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
Oct 16, 2026
Closed $17.49 (-2.8%) on Oct 16, 2026
MiniMed Completes Separation from Medtronic
Oct 15, 2026
Closed $18.00 (+7.1%) on Oct 15, 2026
Medtronic Completes Separation of MiniMed Group, Inc.
Oct 15, 2026
Closed $18.00 (+7.1%) on Oct 15, 2026
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
Oct 14, 2026
Closed $16.81 (-8.6%) on Oct 14, 2026
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
Oct 12, 2026
Closed $18.80 (-4.6%) on Oct 12, 2026
MiniMed Group, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 35 in the last 12 months · 35 in all · newest Nov 17, 2026 · oldest 2026
- Calls
- 2 calls with a replay · 2 with a transcript · latest Sep 1, 2026
- Decks
- 4 decks · latest September 2026
Where MiniMed Group, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MMED · Home listing | NASDAQ | United States | USD |
| gettex:B8S · This page | gettex | Germany | EUR |
| BOATS:MMED | BOATS | United States | USD |
| BX Swiss:MMED | BX Swiss | Switzerland | CHF |
| LS Exchange:A420FV | LS Exchange | Germany | EUR |
| Tradegate:B8S | Tradegate | Germany | EUR |
| Lang & Schwarz:A420FV | Lang & Schwarz | Germany | EUR |
| Dusseldorf:B8S | Dusseldorf | Germany | EUR |
| Frankfurt:B8S | Frankfurt | Germany | EUR |
| Munich:B8S | Munich | Germany | EUR |
| NASDAQ:MMEDV | NASDAQ | United States | USD |
Valuation
Price/book 1.2× against a median of 2.5×: 2nd lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $4.30B USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.2×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.04
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| MiniMed Group, Inc. · NASDAQ:MMED | US$4.50B | US$4.30B | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 1.04 |
| APT Medical Inc. Class A · SSE:688617 | US$6.00B | US$5.73B | 39.3× | 12.4× | n/a | 11.8× | 33.0% | 0.0× | n/a |
| Haemonetics Corporation · NYSE:HAE | US$5.47B | US$6.35B | 52.7× | 4.6× | 22.1× | 6.1× | 7.5% | 1.3× | 0.27 |
| Merit Medical Systems, Inc. · NASDAQ:MMSI | US$5.05B | US$5.29B | 31.6× | 3.3× | 15.4× | 2.9× | 9.9% | 0.4× | 0.49 |
| LivaNova PLC · NASDAQ:LIVN | US$5.00B | US$4.73B | 25.5× | 3.1× | 21.6× | 3.6× | 13.0% | 0.2× | 1.02 |
| Intco Medical Technology Co., Ltd. Class A · SZSE:300677 | US$4.74B | US$3.56B | 106× | 1.8× | n/a | 1.7× | 2.3% | 0.0× | n/a |
| ICU Medical, Inc. · NASDAQ:ICUI | US$4.31B | US$5.16B | 71.5× | 2.4× | 16.6× | 2.0× | 2.8% | 0.5× | 0.99 |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A · SZSE:002223 | US$4.19B | US$3.98B | 24.3× | 3.3× | n/a | 2.2× | 14.3% | 0.0× | n/a |
| IMEIK Technology Development Co., Ltd. Class A · SZSE:300896 | US$3.68B | US$3.14B | 24.8× | 9.0× | n/a | 3.1× | 42.4% | 0.0× | n/a |
| Envista Holdings Corporation · NYSE:NVST | US$3.67B | US$3.94B | 5.8× | 1.4× | 4.7× | 1.2× | 22.0% | 0.5× | 1.18 |
| Shandong Weigao Blood Purification Products Co., Ltd. Class A · SSE:603014 | US$3.54B | US$2.98B | 23.4× | 3.7× | n/a | 2.2× | 18.6% | 0.0× | n/a |
| Median of the others | US$4.53B | US$4.36B | 28.5× | 3.3× | 16.6× | 2.5× | 13.7% | 0.1× | 0.99 |
Forecasts
12 strong buy · 3 hold · 1 sell · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 25.47 USD · Analysts' mean
- EPS, year to Apr 2027
- 0.70 · 11 analysts
- Revenue, year to Apr 2027
- 3.44B · 15 analysts
Team and board
| Officer | Role |
|---|---|
| Que Dallara | Chief Executive Officer |
| Chad Spooner | EVP, Chief Financial Officer |
| Sheila Denton | SVP, General Counsel & Corporate Secretary |
| Ryan Weispfenning | Investor Relations |
| Ali Dianaty | EVP, Chief Product and Technology Officer |
| David Segal | VP, Chief Medical Officer |
| Gillian Chandrasena | SVP, Chief Human Resources Officer |
| Julio Salwen | SVP, Chief Quality Officer |
| Kate Cronin | SVP, Chief Marketing and Communications Officer |
| Laura Endres | SVP, Chief Commercial Officer, Americas |
| Manuel Domenech | SVP, Integrated Supply Chain |
| Mike Bruggeman | SVP, Chief Information Officer |
| Muthu Sabarethinam | SVP, Transformation and Analytics |
| Slobodan Radumilo | SVP, Chief Commercial Officer, EMEA and APAC |
| Yael Glassman | SVP, Chief Strategy and Corporate Development Officer |
| Robert Vigersky | Chief Medical Officer Emeritus |
Events
- Next results
- Nov 24, 2026
Calls
| Call | When | Status |
|---|---|---|
| MiniMed Group (NASDAQ:MMED) Q2 2027 Earnings Call | Tue, Nov 24, 2026 · 8:30 AM ET | Upcoming |
| MiniMed Group (NASDAQ:MMED) Q1 2027 Earnings Call | Tue, Sep 01, 2026 · 8:45 AM ET | Replay |
| MiniMed Group (NASDAQ:MMED) Q4 2026 Earnings Call | Wed, Jun 03, 2026 · 8:45 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q1 2027 | Sep 1, 2026 · Before open | +10.7% |
| Q4 2026 | Jun 3, 2026 · Before open | +15.9% |
| Quarter to Jan 31, 2026 | Apr 1, 2026 | −6.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 42 slides | September 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 26 slides | Sep 1, 2026 |
| Q4 FY2026 Earnings Presentation | Earnings | 32 slides | Jun 3, 2026 |
| Medtronic Diabetes — Fact Sheet (December 2010) | Fact sheet | 2 slides | Dec 31, 2010 |
IPO
Priced at US$20.00 a share on Mar 5, 2026.
- Price
- US$20.00 a share
- Shares offered
- 28,000,000 shares of common stock
- Offering size
- US$560 million
- Underwriters' option
- Up to 4,200,000 more shares
- Listing
- MMED on the Nasdaq Global Select Market
- Underwriters
- Goldman Sachs & Co. LLC, BofA Securities, Citigroup, Morgan Stanley, Barclays, Deutsche Bank Securities, Mizuho, Wells Fargo Securities, Evercore ISI, Piper Sandler, BTIG, William Blair · In the order on the cover
- Shares delivered
- On or about Mar 9, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 30, 2025 |
| Filed publicly | Dec 19, 2025 |
| Amended 3 times | Newest Feb 27, 2026 |
| Shares registered with an exchange | Mar 5, 2026 |
| Declared effective by the SEC | Mar 5, 2026 |
| Final prospectus, with the price | Mar 6, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 6, 2026 |
| EFFECT · Notice that a registration is effective | Mar 5, 2026 |
| CERT · Exchange's certificate of listing | Mar 5, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 5, 2026 |
| S-1/A · Registration statement, amended | Feb 27, 2026 |
| S-1/A · Registration statement, amended | Feb 24, 2026 |
| S-1/A · Registration statement, amended | Jan 23, 2026 |
| S-1 · Registration statement | Dec 19, 2025 |
| DRS/A · Draft registration statement, amended | Oct 28, 2025 |
| DRS/A · Draft registration statement, amended | Aug 27, 2025 |
All 11 filings
| Filing | Filed |
|---|---|
| DRS · Draft registration statement | May 30, 2025 |
Open IPO · From the cover of the final prospectus (424B4) filed Mar 6, 2026
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | 3.10B | 2.71B | 2.47B |
| Cost of revenue | 1.42B | 1.19B | 1.03B |
| Gross profit | 1.68B | 1.53B | 1.44B |
| Research and development | 448.0M | 436.0M | 437.0M |
| Selling, general and administrative | 1.18B | 1.08B | 1.06B |
| Operating income | -190.0M | -146.0M | -69.0M |
| Depreciation and amortization | 156.0M | 143.0M | 129.0M |
| EBITDA | -34.0M | -3.00M | 60.0M |
| Income before tax | -189.0M | -147.0M | -70.0M |
| Income tax | 128.0M | 52.0M | 38.0M |
| Net income | -333.0M | -213.0M | -112.0M |
| Earnings per share, basic | -1.30 | -0.84 | -0.44 |
| Earnings per share, diluted | -1.30 | -0.84 | -0.44 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Cash and equivalents | 298.0M | 11.0M | 54.0M |
| Receivables | 200.0M | 570.0M | |
| Inventory | 341.0M | 311.0M | |
| Current assets | 1.35B | 939.0M | |
| Property, plant and equipment | 711.0M | 706.0M | |
| Goodwill | 2.26B | 2.25B | |
| Total assets | 4.63B | 4.20B | |
| Accounts payable | 163.0M | 205.0M | |
| Current liabilities | 702.0M | 710.0M | |
| Total liabilities | 1.02B | 871.0M | |
| Shareholders' equity | 3.61B | 3.33B | 3.45B |
| Shares outstanding | 280.8M | 0 | 0 |
Cash flow
| Line | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Cash from operations | -197.0M | 140.0M | 41.0M |
| Capital spending | -223.0M | -193.0M | -148.0M |
| Free cash flow | -420.0M | -53.0M | -107.0M |
| Cash from investing | -233.0M | -193.0M | -157.0M |
| Cash from financing | 716.0M | 10.0M | 112.0M |
| Change in cash | 287.0M | -43.0M | -4.00M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 16, 2026 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 30, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 22, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
All 110 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 3 · Initial statement of ownership | Oct 16, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 16, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 16, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 13, 2026 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Oct 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 424B3 · Prospectus | Oct 5, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Oct 1, 2026 | Insider trade | SEC |
| 425 | Sep 21, 2026 | Other filings | SEC |
| 425 | Sep 21, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| 425 | Sep 14, 2026 | Other filings | SEC |
| S-4 · Registration statement | Sep 14, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Sep 8, 2026 | Quarterly report | SEC |
| 8-K · Current report | Sep 1, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Aug 21, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Aug 21, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 21, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 5, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| DRS · Draft registration statement | Jul 29, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Jul 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 6, 2026 | Insider trade | SEC |
| 10-K · Annual report | Jun 29, 2026 | Annual report | SEC |
| 8-K · Current report | Jun 29, 2026 | Management or board change | SEC |
| 8-K · Current report | Jun 3, 2026 | Results | SEC |
| 8-K · Current report | May 18, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | May 6, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 27, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Apr 17, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Mar 27, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 27, 2026 | Management or board change | SEC |
| 8-K · Current report | Mar 25, 2026 | Current report | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 9, 2026 | Offer document | SEC |
| 8-K · Current report | Mar 9, 2026 | Acquisition or disposal | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2026 | Insider trade | SEC |
| 424B4 · Prospectus | Mar 6, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Mar 6, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Mar 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 5, 2026 | Insider trade | SEC |
| CERT · Exchange's certificate of listing | Mar 5, 2026 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Mar 5, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 27, 2026 | Offer document | SEC |
| S-1/A · Registration statement, amended | Feb 24, 2026 | Offer document | SEC |
| S-1/A · Registration statement, amended | Jan 23, 2026 | Offer document | SEC |
| S-1 · Registration statement | Dec 19, 2025 | Offer document | SEC |
| DRS/A · Draft registration statement, amended | Oct 28, 2025 | Offer document | SEC |
| DRS/A · Draft registration statement, amended | Aug 26, 2025 | Offer document | SEC |
| DRS · Draft registration statement | May 29, 2025 | Offer document | SEC |
Cap table
Built by 6ix from MiniMed Group, Inc.’s releases · as of Sep 3, 2026
- Common shares
- 281,349,931
- Fully diluted
- 281,349,931
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 281,349,931 | Sep 3, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Sep 3, 2026 | 281,349,931 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Glenn Eisenberg Other companies: The Middleby Corporation (Independent Director · Since at least Mar 5, 2026); Lumexa Imaging Holdings, Inc. (Director · Since at least Dec 11, 2025); Solventum Corporation (Director · Since at least Apr 1, 2024); Fortrea Holdings Inc. (Executive Vice President, Director · Jun 9, 2023 – Jun 20, 2023 · Past); Perspecta Inc (Director · May 21, 2019 – May 6, 2021 · Past); US Ecology Inc (Director · Feb 2, 2018 – May 2, 2022 · Past); Sequenom Inc (EVP and Treasurer, Director · Sep 7, 2016 – Sep 7, 2016 · Past); Labcorp Holdings Inc. (Executive Vice President · Jun 16, 2014 – Mar 27, 2025 · Past); Alpha Natural Resources Inc (Director · May 17, 2006 – May 22, 2014 · Past); Family Dollar Stores Inc (Director · Jan 19, 2006 – Jul 6, 2015 · Past); Timken Company (the) (Ex VP Finance & Administration · Jan 10, 2006 – Feb 14, 2014 · Past) | Director · Since at least Mar 6, 2026 |
| D. Keith Grossman Other companies: Alcon AG (Board Member · Since at least May 16, 2026); Outset Medical, Inc. (Lead Independent Director · Since at least Sep 14, 2020); Nevro Corp (Director · Mar 19, 2019 – Apr 3, 2025 · Past); Zeltiq Aesthetics Inc (Director · Oct 24, 2013 – Apr 28, 2017 · Past); Conceptus Inc (President & CEO · Dec 13, 2011 – Jun 5, 2013 · Past); Kyphon Inc (Director · Apr 24, 2007 – Nov 2, 2007 · Past); Intuitive Surgical, Inc. (Director · May 19, 2006 – Apr 23, 2010 · Past) | Director · Since at least Mar 6, 2026 |
| Timothy A. Wicks Other companies: GMR Solutions Inc. (Director · Since at least May 13, 2026); BrightSpring Health Services, Inc. (Director · Since at least Apr 24, 2024); Pear Therapeutics Inc (Director · Jun 14, 2022 – Feb 15, 2023 · Past); Precision Castparts Corp (Director · Aug 10, 2010 – Jan 29, 2016 · Past); Aerojet Rocketdyne Holdings Inc (Director · Jan 24, 2006 – Mar 26, 2008 · Past) | Director · Since at least Mar 6, 2026 |
| David J. Endicott Other companies: Alcon AG (Chief Executive Officer · Since at least Aug 10, 2026); Zeltiq Aesthetics Inc (Director · Apr 25, 2016 – Apr 28, 2017 · Past); Hospira Inc (Pres., Hospira Medical Devices · Mar 10, 2014 – Sep 3, 2015 · Past); Orexigen Therapeutics Inc (Director · Nov 29, 2012 – Jul 14, 2017 · Past) | Director · Since at least Jun 29, 2026 |
| Brett A Wall Other companies: Medtronic plc. (EVP & Pres Neuroscience · Since at least Nov 1, 2019); ev3 Inc (Sr. VP, Pres. Int'l Division · Oct 5, 2009 – Jul 9, 2010 · Past) | Director · Since at least Mar 6, 2026 |
| Kevin E Lofton Other companies: Medtronic plc. (Director · Since at least Apr 29, 2024); Gilead Sciences, Inc. (Director · Dec 28, 2023 – Mar 28, 2024 · Past) | Director · Since at least Mar 6, 2026 |
| Que Thanh Dallara Other companies: Lattice Semiconductor Corporation (Director · Since at least Nov 14, 2023); Honeywell International Inc. (President & CEO, HCE · Oct 18, 2018 – Feb 26, 2022 · Past) | Chief Executive Officer, Director · Since at least Mar 6, 2026 |
| Courtney Nelson Wills Other companies: nVent Electric plc (EXECUTIVE VICE PRESIDENT, GENERAL COUNSEL AND CORPORATE SECRETARY · Since at least Sep 29, 2026) | SVP, Gen. Counsel, Corp. Sec. · Since at least Mar 6, 2026 |
| John Gyurci Other companies: Sun Country Airlines Holdings, Inc. (Chief Acct. Off. & VP, Finance · Since at least Mar 16, 2021) | VP, Chief Accounting Officer · Since at least Mar 6, 2026 |
| Laura Mauri Other companies: Medtronic plc. (SVP & Chief Scientific and Medical Officer · Since at least Nov 5, 2026) | Director · Since at least Mar 6, 2026 |
All 32 people
| Person | Seat |
|---|---|
| Matthew R Walter Other companies: Medtronic plc. (SVP, Chief HR Officer · Since at least Jun 24, 2024) | Director · Since at least Mar 6, 2026 |
| Ryan Weispfenning Other companies: Medtronic plc. (Investor Relations · Since at least Feb 24, 2026) | Investor Relations · Since at least Apr 28, 2026 |
| Scott Cundy Other companies: Medtronic plc. (SVP & Chief Quality, Development, & Innovation Officer · Since at least Nov 5, 2026) | Director · Since at least Jul 3, 2026 |
| Sheila Denton Other companies: Incyte Corporation (EVP & General Counsel · Since at least Oct 2, 2023) | SVP, General Counsel & Corporate Secretary · Since at least Sep 28, 2026 |
| Ali Dianaty | EVP, Chief Product and Technology Officer · Since at least Mar 6, 2026 |
| Amy Bricker | Director · Since at least Oct 15, 2026 |
| Brian Sandstrom | Director · Since at least Mar 5, 2026 |
| Chad Spooner | EVP, Chief Financial Officer · Since at least Jul 1, 2026 |
| Christopher Eso | President · Since at least Mar 5, 2026 |
| David Segal | VP, Chief Medical Officer · Since at least Nov 3, 2026 |
| Gillian Chandrasena | SVP, Chief HR Officer · Since at least Mar 6, 2026 |
| Julio Salwen | SVP, Chief Quality Officer · Since at least Nov 5, 2026 |
| Kate Cronin | SVP, Chief Marketing and Communications Officer · Since at least Nov 4, 2026 |
| Laura Endres | SVP, Chief Commercial Officer, Americas · Since at least Nov 5, 2026 |
| Linnea Burman | Director · Since at least Jun 29, 2026 |
| Manuel Domenech | SVP, Integrated Supply Chain · Since at least Nov 5, 2026 |
| Mike Bruggeman | SVP, Chief Information Officer · Since at least Nov 4, 2026 |
| Muthu Sabarethinam | SVP, Transformation and Analytics · Since at least Nov 5, 2026 |
| Robert Hopkins | Director · Since at least Mar 6, 2026 |
| Robert Vigersky | Chief Medical Officer Emeritus · Since at least Nov 3, 2026 |
| Slobodan Radumilo | SVP, Chief Commercial Officer, EMEA and APAC · Since at least Nov 5, 2026 |
| Yael Glassman | SVP, Chief Strategy and Corporate Development Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about MiniMed Group, Inc.